Early Communication About Safety of Lantus (insulin glargine)
Links shared publicly online about this topic.
- 1,929total visits
Early Communication About Safety of Lantus (insulin glargine)
fda.gov —
View full resource at fda.gov
Tags: Diabetes Type 1 Medication, Diabetes Type 2 Medication, Diabetes Medication, Insulin, Cancer, Anxiety Disorder, FDA, Lantus
Most Recently Shared on July 2, 2009 at 4:02 pm By:
Use Lantus insulin? Don't panic about cancer scare #diabetes. Here's FDA's position: http://tinyurl.com/mkc53g
Also Shared By:
FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer
fda.gov — “[1-12-2011] The U.S. Food and Drug Administration (FDA) is updating the public about its ongoing safety review of Lantus (insulin glargine) and a possible increased risk of cancer.” View full resource at fda.gov
Most Recently Shared on January 13, 2011 at 2:49 pm By:
Scott Strumello Patient Expert
FDA Drug Safety Communication: Update to ongoing safety review of Lantus & possible risk of cancer http://t.co/WD685tf
FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer
fda.gov — “[1-12-2011] The U.S. Food and Drug Administration (FDA) is updating the public about its ongoing safety review of Lantus (insulin glargine) and a possible increased risk of cancer.” View full resource at fda.gov
Most Recently Shared on January 13, 2011 at 2:37 pm By:
NCI Cancer Bulletin Health News
FDA provides update on review of possible link between diabetes drug, cancer risk: http://bit.ly/hVDraB
Advertisement
AACE
@TheAACE
FDA Early Communication About Safety of Lantus (insulin glargine) http://bit.ly/10bFXc
1 year ago...